0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sustained-release Microspheres Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-27P18868
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sustained release Microspheres Market Research Report 2025
BUY CHAPTERS

Global Sustained-release Microspheres Market Research Report 2025

Code: QYRE-Auto-27P18868
Report
April 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sustained-release Microspheres Market Size

The global market for Sustained-release Microspheres was valued at US$ 270 million in the year 2024 and is projected to reach a revised size of US$ 378 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Sustained-release Microspheres Market

Sustained-release Microspheres Market

Sustained-release microspheres are specialized drug delivery systems designed to provide controlled and prolonged release of therapeutic agents after injection. These microspheres, typically made from biodegradable polymers like poly(lactic-co-glycolic acid) (PLGA), encapsulate drugs and gradually release them over days, weeks, or even months as the polymer degrades. This technology enhances patient compliance by reducing the frequency of injections, ensures steady drug levels in the bloodstream, and minimizes side effects associated with peak drug concentrations. Sustained-release microspheres are widely used in fields such as oncology, endocrinology, neurology, and infectious diseases, offering benefits in treating cancer, diabetes, schizophrenia, and chronic infections.
The sustained-release microspheres market is experiencing steady growth, driven by increasing demand for controlled drug delivery systems in pharmaceuticals, biotechnology, and healthcare. Sustained-release microspheres are tiny biodegradable polymer-based carriers designed to release drugs gradually over an extended period, improving patient compliance and reducing dosing frequency. They are widely used in oncology, diabetes, cardiovascular diseases, and pain management. Advances in biodegradable polymers like PLGA (poly(lactic-co-glycolic acid)), as well as innovations in encapsulation techniques, have expanded their applications. North America and Europe lead the market due to strong regulatory frameworks and high healthcare spending, while Asia-Pacific is emerging as a key growth region. The rising adoption of injectable microsphere formulations, coupled with ongoing R&D, continues to shape the competitive landscape.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sustained-release Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained-release Microspheres.
The Sustained-release Microspheres market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sustained-release Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sustained-release Microspheres manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sustained-release Microspheres Market Report

Report Metric Details
Report Name Sustained-release Microspheres Market
Accounted market size in year US$ 270 million
Forecasted market size in 2031 US$ 378 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Risperidone Microspheres
  • Leuprorelin Microspheres
  • Octreotide Microspheres
  • Triptorelin Microspheres
  • Others
Segment by Application
  • Malignant Tumors
  • Diabetes
  • Cardiovascular Diseases
  • Mental Illness
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, Shandong Luye Pharmaceutical, Livzon Pharmaceutical, Zhejiang Sundoc Pharmaceutical Science and Tech, Beijing Boente Pharmaceutical, Guangzhou DiQi Pharmaceuticals, Qilu Pharmaceutical, Changchun GeneScience Pharmaceutical, Anhui BBCA Biochemical, Yichang Humanwell Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sustained-release Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sustained-release Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sustained-release Microspheres Market growing?

Ans: The Sustained-release Microspheres Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Sustained-release Microspheres Market size in 2031?

Ans: The Sustained-release Microspheres Market size in 2031 will be US$ 378 million.

Who are the main players in the Sustained-release Microspheres Market report?

Ans: The main players in the Sustained-release Microspheres Market are Novartis, Ferring, Ipsen, Takeda, Roche, AstraZeneca, OraPharma, Alkermes, Pacira BioSciences, Xian Janssen Pharmaceutical, Shandong Luye Pharmaceutical, Livzon Pharmaceutical, Zhejiang Sundoc Pharmaceutical Science and Tech, Beijing Boente Pharmaceutical, Guangzhou DiQi Pharmaceuticals, Qilu Pharmaceutical, Changchun GeneScience Pharmaceutical, Anhui BBCA Biochemical, Yichang Humanwell Pharmaceutical

What are the Application segmentation covered in the Sustained-release Microspheres Market report?

Ans: The Applications covered in the Sustained-release Microspheres Market report are Malignant Tumors, Diabetes, Cardiovascular Diseases, Mental Illness, Others

What are the Type segmentation covered in the Sustained-release Microspheres Market report?

Ans: The Types covered in the Sustained-release Microspheres Market report are Risperidone Microspheres, Leuprorelin Microspheres, Octreotide Microspheres, Triptorelin Microspheres, Others

1 Sustained-release Microspheres Market Overview
1.1 Product Definition
1.2 Sustained-release Microspheres by Type
1.2.1 Global Sustained-release Microspheres Market Value Comparison by Type (2024 VS 2031)
1.2.2 Risperidone Microspheres
1.2.3 Leuprorelin Microspheres
1.2.4 Octreotide Microspheres
1.2.5 Triptorelin Microspheres
1.2.6 Others
1.3 Sustained-release Microspheres by Application
1.3.1 Global Sustained-release Microspheres Market Value by Application (2024 VS 2031)
1.3.2 Malignant Tumors
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Mental Illness
1.3.6 Others
1.4 Global Sustained-release Microspheres Market Size Estimates and Forecasts
1.4.1 Global Sustained-release Microspheres Revenue 2020-2031
1.4.2 Global Sustained-release Microspheres Sales 2020-2031
1.4.3 Global Sustained-release Microspheres Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sustained-release Microspheres Market Competition by Manufacturers
2.1 Global Sustained-release Microspheres Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sustained-release Microspheres Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sustained-release Microspheres Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sustained-release Microspheres, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sustained-release Microspheres, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sustained-release Microspheres, Product Type & Application
2.7 Global Key Manufacturers of Sustained-release Microspheres, Date of Enter into This Industry
2.8 Global Sustained-release Microspheres Market Competitive Situation and Trends
2.8.1 Global Sustained-release Microspheres Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sustained-release Microspheres Players Market Share by Revenue
2.8.3 Global Sustained-release Microspheres Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sustained-release Microspheres Market Scenario by Region
3.1 Global Sustained-release Microspheres Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sustained-release Microspheres Sales by Region: 2020-2031
3.2.1 Global Sustained-release Microspheres Sales by Region: 2020-2025
3.2.2 Global Sustained-release Microspheres Sales by Region: 2026-2031
3.3 Global Sustained-release Microspheres Revenue by Region: 2020-2031
3.3.1 Global Sustained-release Microspheres Revenue by Region: 2020-2025
3.3.2 Global Sustained-release Microspheres Revenue by Region: 2026-2031
3.4 North America Sustained-release Microspheres Market Facts & Figures by Country
3.4.1 North America Sustained-release Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sustained-release Microspheres Sales by Country (2020-2031)
3.4.3 North America Sustained-release Microspheres Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sustained-release Microspheres Market Facts & Figures by Country
3.5.1 Europe Sustained-release Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sustained-release Microspheres Sales by Country (2020-2031)
3.5.3 Europe Sustained-release Microspheres Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sustained-release Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific Sustained-release Microspheres Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sustained-release Microspheres Sales by Region (2020-2031)
3.6.3 Asia Pacific Sustained-release Microspheres Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sustained-release Microspheres Market Facts & Figures by Country
3.7.1 Latin America Sustained-release Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sustained-release Microspheres Sales by Country (2020-2031)
3.7.3 Latin America Sustained-release Microspheres Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sustained-release Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa Sustained-release Microspheres Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sustained-release Microspheres Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sustained-release Microspheres Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sustained-release Microspheres Sales by Type (2020-2031)
4.1.1 Global Sustained-release Microspheres Sales by Type (2020-2025)
4.1.2 Global Sustained-release Microspheres Sales by Type (2026-2031)
4.1.3 Global Sustained-release Microspheres Sales Market Share by Type (2020-2031)
4.2 Global Sustained-release Microspheres Revenue by Type (2020-2031)
4.2.1 Global Sustained-release Microspheres Revenue by Type (2020-2025)
4.2.2 Global Sustained-release Microspheres Revenue by Type (2026-2031)
4.2.3 Global Sustained-release Microspheres Revenue Market Share by Type (2020-2031)
4.3 Global Sustained-release Microspheres Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sustained-release Microspheres Sales by Application (2020-2031)
5.1.1 Global Sustained-release Microspheres Sales by Application (2020-2025)
5.1.2 Global Sustained-release Microspheres Sales by Application (2026-2031)
5.1.3 Global Sustained-release Microspheres Sales Market Share by Application (2020-2031)
5.2 Global Sustained-release Microspheres Revenue by Application (2020-2031)
5.2.1 Global Sustained-release Microspheres Revenue by Application (2020-2025)
5.2.2 Global Sustained-release Microspheres Revenue by Application (2026-2031)
5.2.3 Global Sustained-release Microspheres Revenue Market Share by Application (2020-2031)
5.3 Global Sustained-release Microspheres Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Sustained-release Microspheres Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Ferring
6.2.1 Ferring Company Information
6.2.2 Ferring Description and Business Overview
6.2.3 Ferring Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ferring Sustained-release Microspheres Product Portfolio
6.2.5 Ferring Recent Developments/Updates
6.3 Ipsen
6.3.1 Ipsen Company Information
6.3.2 Ipsen Description and Business Overview
6.3.3 Ipsen Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ipsen Sustained-release Microspheres Product Portfolio
6.3.5 Ipsen Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Sustained-release Microspheres Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Sustained-release Microspheres Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Sustained-release Microspheres Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 OraPharma
6.7.1 OraPharma Company Information
6.7.2 OraPharma Description and Business Overview
6.7.3 OraPharma Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OraPharma Sustained-release Microspheres Product Portfolio
6.7.5 OraPharma Recent Developments/Updates
6.8 Alkermes
6.8.1 Alkermes Company Information
6.8.2 Alkermes Description and Business Overview
6.8.3 Alkermes Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Alkermes Sustained-release Microspheres Product Portfolio
6.8.5 Alkermes Recent Developments/Updates
6.9 Pacira BioSciences
6.9.1 Pacira BioSciences Company Information
6.9.2 Pacira BioSciences Description and Business Overview
6.9.3 Pacira BioSciences Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pacira BioSciences Sustained-release Microspheres Product Portfolio
6.9.5 Pacira BioSciences Recent Developments/Updates
6.10 Xian Janssen Pharmaceutical
6.10.1 Xian Janssen Pharmaceutical Company Information
6.10.2 Xian Janssen Pharmaceutical Description and Business Overview
6.10.3 Xian Janssen Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xian Janssen Pharmaceutical Sustained-release Microspheres Product Portfolio
6.10.5 Xian Janssen Pharmaceutical Recent Developments/Updates
6.11 Shandong Luye Pharmaceutical
6.11.1 Shandong Luye Pharmaceutical Company Information
6.11.2 Shandong Luye Pharmaceutical Description and Business Overview
6.11.3 Shandong Luye Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shandong Luye Pharmaceutical Sustained-release Microspheres Product Portfolio
6.11.5 Shandong Luye Pharmaceutical Recent Developments/Updates
6.12 Livzon Pharmaceutical
6.12.1 Livzon Pharmaceutical Company Information
6.12.2 Livzon Pharmaceutical Description and Business Overview
6.12.3 Livzon Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Livzon Pharmaceutical Sustained-release Microspheres Product Portfolio
6.12.5 Livzon Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Sundoc Pharmaceutical Science and Tech
6.13.1 Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
6.13.2 Zhejiang Sundoc Pharmaceutical Science and Tech Description and Business Overview
6.13.3 Zhejiang Sundoc Pharmaceutical Science and Tech Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zhejiang Sundoc Pharmaceutical Science and Tech Sustained-release Microspheres Product Portfolio
6.13.5 Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments/Updates
6.14 Beijing Boente Pharmaceutical
6.14.1 Beijing Boente Pharmaceutical Company Information
6.14.2 Beijing Boente Pharmaceutical Description and Business Overview
6.14.3 Beijing Boente Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing Boente Pharmaceutical Sustained-release Microspheres Product Portfolio
6.14.5 Beijing Boente Pharmaceutical Recent Developments/Updates
6.15 Guangzhou DiQi Pharmaceuticals
6.15.1 Guangzhou DiQi Pharmaceuticals Company Information
6.15.2 Guangzhou DiQi Pharmaceuticals Description and Business Overview
6.15.3 Guangzhou DiQi Pharmaceuticals Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Guangzhou DiQi Pharmaceuticals Sustained-release Microspheres Product Portfolio
6.15.5 Guangzhou DiQi Pharmaceuticals Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Qilu Pharmaceutical Sustained-release Microspheres Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Changchun GeneScience Pharmaceutical
6.17.1 Changchun GeneScience Pharmaceutical Company Information
6.17.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.17.3 Changchun GeneScience Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Changchun GeneScience Pharmaceutical Sustained-release Microspheres Product Portfolio
6.17.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.18 Anhui BBCA Biochemical
6.18.1 Anhui BBCA Biochemical Company Information
6.18.2 Anhui BBCA Biochemical Description and Business Overview
6.18.3 Anhui BBCA Biochemical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Anhui BBCA Biochemical Sustained-release Microspheres Product Portfolio
6.18.5 Anhui BBCA Biochemical Recent Developments/Updates
6.19 Yichang Humanwell Pharmaceutical
6.19.1 Yichang Humanwell Pharmaceutical Company Information
6.19.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.19.3 Yichang Humanwell Pharmaceutical Sustained-release Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Yichang Humanwell Pharmaceutical Sustained-release Microspheres Product Portfolio
6.19.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sustained-release Microspheres Industry Chain Analysis
7.2 Sustained-release Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sustained-release Microspheres Production Mode & Process Analysis
7.4 Sustained-release Microspheres Sales and Marketing
7.4.1 Sustained-release Microspheres Sales Channels
7.4.2 Sustained-release Microspheres Distributors
7.5 Sustained-release Microspheres Customer Analysis
8 Sustained-release Microspheres Market Dynamics
8.1 Sustained-release Microspheres Industry Trends
8.2 Sustained-release Microspheres Market Drivers
8.3 Sustained-release Microspheres Market Challenges
8.4 Sustained-release Microspheres Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sustained-release Microspheres Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sustained-release Microspheres Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sustained-release Microspheres Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sustained-release Microspheres Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sustained-release Microspheres Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sustained-release Microspheres Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sustained-release Microspheres Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sustained-release Microspheres Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sustained-release Microspheres, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sustained-release Microspheres, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sustained-release Microspheres, Product Type & Application
 Table 12. Global Key Manufacturers of Sustained-release Microspheres, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sustained-release Microspheres by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained-release Microspheres as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sustained-release Microspheres Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sustained-release Microspheres Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sustained-release Microspheres Sales Market Share by Region (2020-2025)
 Table 19. Global Sustained-release Microspheres Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sustained-release Microspheres Sales Market Share by Region (2026-2031)
 Table 21. Global Sustained-release Microspheres Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sustained-release Microspheres Revenue Market Share by Region (2020-2025)
 Table 23. Global Sustained-release Microspheres Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sustained-release Microspheres Revenue Market Share by Region (2026-2031)
 Table 25. North America Sustained-release Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sustained-release Microspheres Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sustained-release Microspheres Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sustained-release Microspheres Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sustained-release Microspheres Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sustained-release Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sustained-release Microspheres Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sustained-release Microspheres Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sustained-release Microspheres Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sustained-release Microspheres Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sustained-release Microspheres Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sustained-release Microspheres Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sustained-release Microspheres Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sustained-release Microspheres Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sustained-release Microspheres Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sustained-release Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sustained-release Microspheres Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sustained-release Microspheres Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sustained-release Microspheres Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sustained-release Microspheres Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sustained-release Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sustained-release Microspheres Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sustained-release Microspheres Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sustained-release Microspheres Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sustained-release Microspheres Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sustained-release Microspheres Sales (K Units) by Type (2020-2025)
 Table 51. Global Sustained-release Microspheres Sales (K Units) by Type (2026-2031)
 Table 52. Global Sustained-release Microspheres Sales Market Share by Type (2020-2025)
 Table 53. Global Sustained-release Microspheres Sales Market Share by Type (2026-2031)
 Table 54. Global Sustained-release Microspheres Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sustained-release Microspheres Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sustained-release Microspheres Revenue Market Share by Type (2020-2025)
 Table 57. Global Sustained-release Microspheres Revenue Market Share by Type (2026-2031)
 Table 58. Global Sustained-release Microspheres Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sustained-release Microspheres Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sustained-release Microspheres Sales (K Units) by Application (2020-2025)
 Table 61. Global Sustained-release Microspheres Sales (K Units) by Application (2026-2031)
 Table 62. Global Sustained-release Microspheres Sales Market Share by Application (2020-2025)
 Table 63. Global Sustained-release Microspheres Sales Market Share by Application (2026-2031)
 Table 64. Global Sustained-release Microspheres Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sustained-release Microspheres Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sustained-release Microspheres Revenue Market Share by Application (2020-2025)
 Table 67. Global Sustained-release Microspheres Revenue Market Share by Application (2026-2031)
 Table 68. Global Sustained-release Microspheres Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sustained-release Microspheres Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Sustained-release Microspheres Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Ferring Company Information
 Table 76. Ferring Description and Business Overview
 Table 77. Ferring Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ferring Sustained-release Microspheres Product
 Table 79. Ferring Recent Developments/Updates
 Table 80. Ipsen Company Information
 Table 81. Ipsen Description and Business Overview
 Table 82. Ipsen Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ipsen Sustained-release Microspheres Product
 Table 84. Ipsen Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Takeda Sustained-release Microspheres Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Roche Sustained-release Microspheres Product
 Table 94. Roche Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AstraZeneca Sustained-release Microspheres Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. OraPharma Company Information
 Table 101. OraPharma Description and Business Overview
 Table 102. OraPharma Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. OraPharma Sustained-release Microspheres Product
 Table 104. OraPharma Recent Developments/Updates
 Table 105. Alkermes Company Information
 Table 106. Alkermes Description and Business Overview
 Table 107. Alkermes Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Alkermes Sustained-release Microspheres Product
 Table 109. Alkermes Recent Developments/Updates
 Table 110. Pacira BioSciences Company Information
 Table 111. Pacira BioSciences Description and Business Overview
 Table 112. Pacira BioSciences Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pacira BioSciences Sustained-release Microspheres Product
 Table 114. Pacira BioSciences Recent Developments/Updates
 Table 115. Xian Janssen Pharmaceutical Company Information
 Table 116. Xian Janssen Pharmaceutical Description and Business Overview
 Table 117. Xian Janssen Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Xian Janssen Pharmaceutical Sustained-release Microspheres Product
 Table 119. Xian Janssen Pharmaceutical Recent Developments/Updates
 Table 120. Shandong Luye Pharmaceutical Company Information
 Table 121. Shandong Luye Pharmaceutical Description and Business Overview
 Table 122. Shandong Luye Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shandong Luye Pharmaceutical Sustained-release Microspheres Product
 Table 124. Shandong Luye Pharmaceutical Recent Developments/Updates
 Table 125. Livzon Pharmaceutical Company Information
 Table 126. Livzon Pharmaceutical Description and Business Overview
 Table 127. Livzon Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Livzon Pharmaceutical Sustained-release Microspheres Product
 Table 129. Livzon Pharmaceutical Recent Developments/Updates
 Table 130. Zhejiang Sundoc Pharmaceutical Science and Tech Company Information
 Table 131. Zhejiang Sundoc Pharmaceutical Science and Tech Description and Business Overview
 Table 132. Zhejiang Sundoc Pharmaceutical Science and Tech Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Zhejiang Sundoc Pharmaceutical Science and Tech Sustained-release Microspheres Product
 Table 134. Zhejiang Sundoc Pharmaceutical Science and Tech Recent Developments/Updates
 Table 135. Beijing Boente Pharmaceutical Company Information
 Table 136. Beijing Boente Pharmaceutical Description and Business Overview
 Table 137. Beijing Boente Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Beijing Boente Pharmaceutical Sustained-release Microspheres Product
 Table 139. Beijing Boente Pharmaceutical Recent Developments/Updates
 Table 140. Guangzhou DiQi Pharmaceuticals Company Information
 Table 141. Guangzhou DiQi Pharmaceuticals Description and Business Overview
 Table 142. Guangzhou DiQi Pharmaceuticals Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Guangzhou DiQi Pharmaceuticals Sustained-release Microspheres Product
 Table 144. Guangzhou DiQi Pharmaceuticals Recent Developments/Updates
 Table 145. Qilu Pharmaceutical Company Information
 Table 146. Qilu Pharmaceutical Description and Business Overview
 Table 147. Qilu Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Qilu Pharmaceutical Sustained-release Microspheres Product
 Table 149. Qilu Pharmaceutical Recent Developments/Updates
 Table 150. Changchun GeneScience Pharmaceutical Company Information
 Table 151. Changchun GeneScience Pharmaceutical Description and Business Overview
 Table 152. Changchun GeneScience Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Changchun GeneScience Pharmaceutical Sustained-release Microspheres Product
 Table 154. Changchun GeneScience Pharmaceutical Recent Developments/Updates
 Table 155. Anhui BBCA Biochemical Company Information
 Table 156. Anhui BBCA Biochemical Description and Business Overview
 Table 157. Anhui BBCA Biochemical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Anhui BBCA Biochemical Sustained-release Microspheres Product
 Table 159. Anhui BBCA Biochemical Recent Developments/Updates
 Table 160. Yichang Humanwell Pharmaceutical Company Information
 Table 161. Yichang Humanwell Pharmaceutical Description and Business Overview
 Table 162. Yichang Humanwell Pharmaceutical Sustained-release Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Yichang Humanwell Pharmaceutical Sustained-release Microspheres Product
 Table 164. Yichang Humanwell Pharmaceutical Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Sustained-release Microspheres Distributors List
 Table 168. Sustained-release Microspheres Customers List
 Table 169. Sustained-release Microspheres Market Trends
 Table 170. Sustained-release Microspheres Market Drivers
 Table 171. Sustained-release Microspheres Market Challenges
 Table 172. Sustained-release Microspheres Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sustained-release Microspheres
 Figure 2. Global Sustained-release Microspheres Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sustained-release Microspheres Market Share by Type: 2024 & 2031
 Figure 4. Risperidone Microspheres Product Picture
 Figure 5. Leuprorelin Microspheres Product Picture
 Figure 6. Octreotide Microspheres Product Picture
 Figure 7. Triptorelin Microspheres Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Sustained-release Microspheres Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Sustained-release Microspheres Market Share by Application: 2024 & 2031
 Figure 11. Malignant Tumors
 Figure 12. Diabetes
 Figure 13. Cardiovascular Diseases
 Figure 14. Mental Illness
 Figure 15. Others
 Figure 16. Global Sustained-release Microspheres Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Sustained-release Microspheres Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Sustained-release Microspheres Sales (2020-2031) & (K Units)
 Figure 19. Global Sustained-release Microspheres Average Price (US$/Unit) & (2020-2031)
 Figure 20. Sustained-release Microspheres Report Years Considered
 Figure 21. Sustained-release Microspheres Sales Share by Manufacturers in 2024
 Figure 22. Global Sustained-release Microspheres Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Sustained-release Microspheres Players: Market Share by Revenue in Sustained-release Microspheres in 2024
 Figure 24. Sustained-release Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Sustained-release Microspheres Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Sustained-release Microspheres Sales Market Share by Country (2020-2031)
 Figure 27. North America Sustained-release Microspheres Revenue Market Share by Country (2020-2031)
 Figure 28. United States Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Sustained-release Microspheres Sales Market Share by Country (2020-2031)
 Figure 31. Europe Sustained-release Microspheres Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Sustained-release Microspheres Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Sustained-release Microspheres Revenue Market Share by Region (2020-2031)
 Figure 39. China Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Sustained-release Microspheres Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Sustained-release Microspheres Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Colombia Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Sustained-release Microspheres Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Sustained-release Microspheres Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Sustained-release Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Sustained-release Microspheres by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Sustained-release Microspheres by Type (2020-2031)
 Figure 59. Global Sustained-release Microspheres Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Sustained-release Microspheres by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Sustained-release Microspheres by Application (2020-2031)
 Figure 62. Global Sustained-release Microspheres Price (US$/Unit) by Application (2020-2031)
 Figure 63. Sustained-release Microspheres Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart